StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 07 Jul 2026 09:03:04 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Penumbra enrolls first patient in stroke thrombectomy study http://www.streetinsider.com/Corporate+News/Penumbra+enrolls+first+patient+in+stroke+thrombectomy+study/26739700.html <p>Penumbra, Inc. (NYSE: PEN) has enrolled the first patient in its FORWARD study, an international, prospective, multi-center trial evaluating mechanical thrombectomy for distal acute ischemic stroke, according to a company press release.</p><p>The first patient was treated by Keith Woodward, M.D., a neurointerventional radiologist at Vista Radiology in Knoxville, Tenn. The study plans to enroll up to 250 participants across approximately 40 sites.</p><p>FORWARD — an acronym for Functional Outcomes in Real-World Treatment and Revascularization of Non-dominant and Distal M2 Occlusions — will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT) and modulated aspiration, for strokes http://www.streetinsider.com/Corporate+News/Penumbra+enrolls+first+patient+in+stroke+thrombectomy+study/26739700.html Tue, 07 Jul 2026 09:03:04 -0400 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/Press+Releases/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>July 7, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4726376-1&h=575959172&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT™) and modulated aspiration, in the management of acute ischemic stroke with distal occlusions. The first patient was treated by <person>Keith Woodward</person>, M.D., neurointerventional radiologist at <span value="ACORN:4024512766" idsrc="xmltag.org" >Vista Radiology</span> in <location value="LU/us.tn.knxvle" idsrc="xmltag.org" >Knoxville, Tenn.</location> </p> <div http://www.streetinsider.com/PRNewswire/First+Patient+Enrolled+in+Penumbra%27s+FORWARD+Study+Evaluating+Mechanical+Thrombectomy+and+Computer+Assisted+Vacuum+Thrombectomy+for+Distal+Acute+Ischemic+Stroke/26739619.html Tue, 07 Jul 2026 09:00:00 -0400 A.08686595 A.31004219 A.40245127 O.00050712 O.00160367 O.01770044 O.20187192 PEN Form 8-K Penumbra Inc For: Jun 18 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Penumbra+Inc++++++++++++++For%3A+Jun+18/26673384.html si-local-file:///var/storage/secattach/20260622/26673384.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Penumbra+Inc++++++++++++++For%3A+Jun+18/26673384.html Mon, 22 Jun 2026 16:19:00 -0400 O.01770044 PEN Form 8-K Penumbra Inc For: Jun 18 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Penumbra+Inc++++++++++++++For%3A+Jun+18/26673384.html si-local-file:///var/storage/secattach/20260622/26673384.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Penumbra+Inc++++++++++++++For%3A+Jun+18/26673384.html Mon, 22 Jun 2026 16:19:00 -0400 O.01770044 PEN Penumbra gets CE Mark for THUNDERBOLT stroke device in Europe http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html <p>Penumbra Inc. (NYSE: PEN) announced it received CE Mark approval in Europe for its THUNDERBOLT computer assisted vacuum thrombectomy device for treating acute ischemic stroke. The company obtained U.S. Food and Drug Administration clearance for the device last week.</p> <p>THUNDERBOLT uses modulated aspiration technology designed to detect, fatigue and remove blood clots at the site of blockage in stroke patients. The device is powered by Penumbra's ENGINE technology and represents the company's introduction of computer assisted vacuum thrombectomy to neurovascular care.</p> <p>The device will be packaged with one of Penumbra's catheters including RED 62, RED 68, RED 72 SILVER LABEL or RED http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html Mon, 15 Jun 2026 09:00:59 -0400 A.06822034 O.01770044 O.20026344 PEN Penumbra gets CE Mark for THUNDERBOLT stroke device in Europe http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html <p>Penumbra Inc. (NYSE: PEN) announced it received CE Mark approval in Europe for its THUNDERBOLT computer assisted vacuum thrombectomy device for treating acute ischemic stroke. The company obtained U.S. Food and Drug Administration clearance for the device last week.</p> <p>THUNDERBOLT uses modulated aspiration technology designed to detect, fatigue and remove blood clots at the site of blockage in stroke patients. The device is powered by Penumbra's ENGINE technology and represents the company's introduction of computer assisted vacuum thrombectomy to neurovascular care.</p> <p>The device will be packaged with one of Penumbra's catheters including RED 62, RED 68, RED 72 SILVER LABEL or RED http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html Mon, 15 Jun 2026 09:00:59 -0400 A.06822034 O.01770044 O.20026344 PEN Penumbra gets CE Mark for THUNDERBOLT stroke device in Europe http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html <p>Penumbra Inc. (NYSE: PEN) announced it received CE Mark approval in Europe for its THUNDERBOLT computer assisted vacuum thrombectomy device for treating acute ischemic stroke. The company obtained U.S. Food and Drug Administration clearance for the device last week.</p> <p>THUNDERBOLT uses modulated aspiration technology designed to detect, fatigue and remove blood clots at the site of blockage in stroke patients. The device is powered by Penumbra's ENGINE technology and represents the company's introduction of computer assisted vacuum thrombectomy to neurovascular care.</p> <p>The device will be packaged with one of Penumbra's catheters including RED 62, RED 68, RED 72 SILVER LABEL or RED http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html Mon, 15 Jun 2026 09:00:59 -0400 A.06822034 O.01770044 O.20026344 PEN Penumbra gets CE Mark for THUNDERBOLT stroke device in Europe http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html <p>Penumbra Inc. (NYSE: PEN) announced it received CE Mark approval in Europe for its THUNDERBOLT computer assisted vacuum thrombectomy device for treating acute ischemic stroke. The company obtained U.S. Food and Drug Administration clearance for the device last week.</p> <p>THUNDERBOLT uses modulated aspiration technology designed to detect, fatigue and remove blood clots at the site of blockage in stroke patients. The device is powered by Penumbra's ENGINE technology and represents the company's introduction of computer assisted vacuum thrombectomy to neurovascular care.</p> <p>The device will be packaged with one of Penumbra's catheters including RED 62, RED 68, RED 72 SILVER LABEL or RED http://www.streetinsider.com/FDA/Penumbra+gets+CE+Mark+for+THUNDERBOLT+stroke+device+in+Europe/26645056.html Mon, 15 Jun 2026 09:00:59 -0400 A.06822034 O.01770044 O.20026344 PEN Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT http://www.streetinsider.com/Press+Releases/Penumbra+Expands+CAVT+for+Stroke+to+Europe+with+CE+Mark+for+THUNDERBOLT/26645031.html <div class="xn-content"> <p class="prntac"><i>The THUNDERBOLT</i><i><sup> TM</sup></i><i> Computer Assisted Vacuum Thrombectomy (CAVT</i><i><sup>TM</sup></i><i>) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 15, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4710904-1&h=3711985443&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has secured CE Mark in Europe for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4710904-1&h=2310425521&u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, further laying the groundwork for launching computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke globally. The company received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> clearance last week.</p> http://www.streetinsider.com/Press+Releases/Penumbra+Expands+CAVT+for+Stroke+to+Europe+with+CE+Mark+for+THUNDERBOLT/26645031.html Mon, 15 Jun 2026 09:00:00 -0400 A.06822034 O.01770044 O.20026344 PEN Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT http://www.streetinsider.com/Press+Releases/Penumbra+Expands+CAVT+for+Stroke+to+Europe+with+CE+Mark+for+THUNDERBOLT/26645031.html <div class="xn-content"> <p class="prntac"><i>The THUNDERBOLT</i><i><sup> TM</sup></i><i> Computer Assisted Vacuum Thrombectomy (CAVT</i><i><sup>TM</sup></i><i>) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 15, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4710904-1&h=3711985443&u=https%3A%2F%2Fwww.penumbrainc.com%2F&a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has secured CE Mark in Europe for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4710904-1&h=2310425521&u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, further laying the groundwork for launching computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke globally. The company received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> clearance last week.</p> http://www.streetinsider.com/Press+Releases/Penumbra+Expands+CAVT+for+Stroke+to+Europe+with+CE+Mark+for+THUNDERBOLT/26645031.html Mon, 15 Jun 2026 09:00:00 -0400 A.06822034 O.01770044 O.20026344 PEN